Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Alexza Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

05 Feb 2016 Reuters Investment Profile 12 $20.00

ValuEngine Rating and Forecast Report for ALXA

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

07 Feb 2016 ValuEngine, Inc. 11 $25.00

ALEXZA PHARMACEUTICALS INC (ALXA=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

06 Feb 2016 Pechala's Reports 2 $25.00

Thomson Reuters Stock Report - Alexza Pharmaceuticals Inc (ALXA-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

05 Feb 2016 Thomson Reuters Stock Report 12 $25.00

Value Graph: ALEXZA PHARMACEU -- ALXA

05 Feb 2016 Ford Investor Services, Inc. 1 $12.00

Wright Investors Service Comprehensive Report for Alexza Pharmaceuticals, Inc.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

31 Jan 2016 Wright Reports 56 $75.00

Alexza Pharmaceuticals

09 Jan 2016 S&P Capital IQ Quantitative Report 10 $115.00

Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review

Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review Summary Alexza Pharmaceuticals, Inc. (Alex...

08 Jan 2016 GlobalData 80 $300.00

Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review

Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review Summary Alexza Pharmaceuticals, Inc. (Alex...

03 Dec 2015 GlobalData 84 $300.00

ALEXZA PHARMACEUTICALS - REGAINING ADASUVE RIGHTS AMID STRATEGIC REVIEW

Alexza and Teva have reached an agreement whereby Alexza will reacquire the US commercial rights for Adasuve, with a projecte...

01 Dec 2015 Edison Investment Research 9 $10.00